APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bioassay and Potency Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bioassay and Potency Testing Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchBioassay and Potency Testing Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Bioassay and Potency Testing Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Bioassay and Potency Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bioassay and Potency Testing Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Bioassay and Potency Testing Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Bioassay and Potency Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bioassay and Potency Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bioassay and Potency Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bioassay and Potency Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bioassay and Potency Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bioassay and Potency Testing market include Eurofins, Vimta Labs Ltd., WaveCyte BioLabs, Reaction Biology, Charles River Laboratories, Intertek, Pacific BioLabs, FyoniBio and Svar Life Science, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Bioassay and Potency Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bioassay and Potency Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bioassay and Potency Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Bioassay and Potency Testing market.

Bioassay and Potency Testing Segment by Company

Eurofins

Vimta Labs Ltd.

WaveCyte BioLabs

Reaction Biology

Charles River Laboratories

Intertek

Pacific BioLabs

FyoniBio

Svar Life Science

Solvias

Bioassay GmbH

Clean Cells

Bioassay and Potency Testing Segment by Type

In Vitro Assay

In Vivo Assay

Bioassay and Potency Testing Segment by Application

Drug Development

Scientific Research

Other

Bioassay and Potency Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bioassay and Potency Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Bioassay and Potency Testing key companies, revenue, market share, and recent developments.

3. To split the Bioassay and Potency Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Bioassay and Potency Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bioassay and Potency Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Bioassay and Potency Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioassay and Potency Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bioassay and Potency Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioassay and Potency Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bioassay and Potency Testing industry.

Chapter 3: Detailed analysis of Bioassay and Potency Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Bioassay and Potency Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Bioassay and Potency Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bioassay and Potency Testing Industry Trends Table 2. Bioassay and Potency Testing Industry Drivers Table 3. Bioassay and Potency Testing Industry Opportunities and Challenges Table 4. Bioassay and Potency Testing Industry Restraints Table 5. Global Bioassay and Potency Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bioassay and Potency Testing Revenue Share by Company (2021-2026) Table 7. Global Bioassay and Potency Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Bioassay and Potency Testing Key Company Manufacturing Base & Headquarters Table 9. Global Bioassay and Potency Testing Company, Product Type & Application Table 10. Global Bioassay and Potency Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Bioassay and Potency Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of In Vitro Assay Table 15. Significant Companies of In Vivo Assay Table 16. Global Bioassay and Potency Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Bioassay and Potency Testing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Bioassay and Potency Testing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Bioassay and Potency Testing Sales Value Share by Type (2021-2026) Table 20. Global Bioassay and Potency Testing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Drug Development Table 22. Significant Companies of Scientific Research Table 23. Significant Companies of Other Table 24. Global Bioassay and Potency Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Bioassay and Potency Testing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Bioassay and Potency Testing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Bioassay and Potency Testing Sales Value Share by Application (2021-2026) Table 28. Global Bioassay and Potency Testing Sales Value Share by Application (2027-2032) Table 29. Global Bioassay and Potency Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Bioassay and Potency Testing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Bioassay and Potency Testing Sales Value Share by Region (2021-2026) Table 32. Global Bioassay and Potency Testing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Bioassay and Potency Testing Sales Value Share by Region (2027-2032) Table 34. Global Bioassay and Potency Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Bioassay and Potency Testing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Bioassay and Potency Testing Sales Value Market Share by Country (2021-2026) Table 37. Global Bioassay and Potency Testing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Bioassay and Potency Testing Sales Value Market Share by Country (2027-2032) Table 39. Eurofins Company Information Table 40. Eurofins Business Overview Table 41. Eurofins Bioassay and Potency Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Eurofins Bioassay and Potency Testing Product Portfolio Table 43. Eurofins Recent Development Table 44. Vimta Labs Ltd. Company Information Table 45. Vimta Labs Ltd. Business Overview Table 46. Vimta Labs Ltd. Bioassay and Potency Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Vimta Labs Ltd. Bioassay and Potency Testing Product Portfolio Table 48. Vimta Labs Ltd. Recent Development Table 49. WaveCyte BioLabs Company Information Table 50. WaveCyte BioLabs Business Overview Table 51. WaveCyte BioLabs Bioassay and Potency Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. WaveCyte BioLabs Bioassay and Potency Testing Product Portfolio Table 53. WaveCyte BioLabs Recent Development Table 54. Reaction Biology Company Information Table 55. Reaction Biology Business Overview Table 56. Reaction Biology Bioassay and Potency Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Reaction Biology Bioassay and Potency Testing Product Portfolio Table 58. Reaction Biology Recent Development Table 59. Charles River Laboratories Company Information Table 60. Charles River Laboratories Business Overview Table 61. Charles River Laboratories Bioassay and Potency Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Charles River Laboratories Bioassay and Potency Testing Product Portfolio Table 63. Charles River Laboratories Recent Development Table 64. Intertek Company Information Table 65. Intertek Business Overview Table 66. Intertek Bioassay and Potency Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Intertek Bioassay and Potency Testing Product Portfolio Table 68. Intertek Recent Development Table 69. Pacific BioLabs Company Information Table 70. Pacific BioLabs Business Overview Table 71. Pacific BioLabs Bioassay and Potency Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Pacific BioLabs Bioassay and Potency Testing Product Portfolio Table 73. Pacific BioLabs Recent Development Table 74. FyoniBio Company Information Table 75. FyoniBio Business Overview Table 76. FyoniBio Bioassay and Potency Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. FyoniBio Bioassay and Potency Testing Product Portfolio Table 78. FyoniBio Recent Development Table 79. Svar Life Science Company Information Table 80. Svar Life Science Business Overview Table 81. Svar Life Science Bioassay and Potency Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Svar Life Science Bioassay and Potency Testing Product Portfolio Table 83. Svar Life Science Recent Development Table 84. Solvias Company Information Table 85. Solvias Business Overview Table 86. Solvias Bioassay and Potency Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Solvias Bioassay and Potency Testing Product Portfolio Table 88. Solvias Recent Development Table 89. Bioassay GmbH Company Information Table 90. Bioassay GmbH Business Overview Table 91. Bioassay GmbH Bioassay and Potency Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Bioassay GmbH Bioassay and Potency Testing Product Portfolio Table 93. Bioassay GmbH Recent Development Table 94. Clean Cells Company Information Table 95. Clean Cells Business Overview Table 96. Clean Cells Bioassay and Potency Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Clean Cells Bioassay and Potency Testing Product Portfolio Table 98. Clean Cells Recent Development Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Bioassay and Potency Testing Product Image Figure 2. Global Bioassay and Potency Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bioassay and Potency Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Bioassay and Potency Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. In Vitro Assay Image Figure 8. In Vivo Assay Image Figure 9. Global Bioassay and Potency Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Bioassay and Potency Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Bioassay and Potency Testing Sales Value Share by Type (2021-2032) Figure 12. Drug Development Image Figure 13. Scientific Research Image Figure 14. Other Image Figure 15. Global Bioassay and Potency Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Bioassay and Potency Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Bioassay and Potency Testing Sales Value Share by Application (2021-2032) Figure 18. Global Bioassay and Potency Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Bioassay and Potency Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Bioassay and Potency Testing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Bioassay and Potency Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Bioassay and Potency Testing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Bioassay and Potency Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Bioassay and Potency Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Bioassay and Potency Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Bioassay and Potency Testing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Bioassay and Potency Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Bioassay and Potency Testing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Bioassay and Potency Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Bioassay and Potency Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • In Vitro Assay
  • In Vivo Assay
Applications
  • Drug Development
  • Scientific Research
  • Other
Companies covered
  • Eurofins
  • Vimta Labs Ltd.
  • WaveCyte BioLabs
  • Reaction Biology
  • Charles River Laboratories
  • Intertek
  • Pacific BioLabs
  • FyoniBio
  • Svar Life Science
  • Solvias
  • Bioassay GmbH
  • Clean Cells

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bioassay and Potency Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bioassay and Potency Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Bioassay and Potency Testing Market Dynamics
  1. 2.1 Bioassay and Potency Testing Industry Trends
  2. 2.2 Bioassay and Potency Testing Industry Drivers
  3. 2.3 Bioassay and Potency Testing Industry Opportunities and Challenges
  4. 2.4 Bioassay and Potency Testing Industry Restraints
3 Bioassay and Potency Testing Market by Company
  1. 3.1 Global Bioassay and Potency Testing Company Revenue Ranking in 2025
  2. 3.2 Global Bioassay and Potency Testing Revenue by Company (2021-2026)
  3. 3.3 Global Bioassay and Potency Testing Company Ranking (2024-2026)
  4. 3.4 Global Bioassay and Potency Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Bioassay and Potency Testing Company Product Type and Application
  6. 3.6 Global Bioassay and Potency Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Bioassay and Potency Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Bioassay and Potency Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Bioassay and Potency Testing Market by Type
  1. 4.1 Bioassay and Potency Testing Type Introduction
  2. 4.1.1 In Vitro Assay
  3. 4.1.2 In Vivo Assay
  4. 4.2 Global Bioassay and Potency Testing Sales Value by Type
  5. 4.2.1 Global Bioassay and Potency Testing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bioassay and Potency Testing Sales Value by Type (2021-2032)
  7. 4.2.3 Global Bioassay and Potency Testing Sales Value Share by Type (2021-2032)
5 Bioassay and Potency Testing Market by Application
  1. 5.1 Bioassay and Potency Testing Application Introduction
  2. 5.1.1 Drug Development
  3. 5.1.2 Scientific Research
  4. 5.1.3 Other
  5. 5.2 Global Bioassay and Potency Testing Sales Value by Application
  6. 5.2.1 Global Bioassay and Potency Testing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bioassay and Potency Testing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Bioassay and Potency Testing Sales Value Share by Application (2021-2032)
6 Bioassay and Potency Testing Regional Value Analysis
  1. 6.1 Global Bioassay and Potency Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bioassay and Potency Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Bioassay and Potency Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Bioassay and Potency Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bioassay and Potency Testing Sales Value (2021-2032)
  7. 6.3.2 North America Bioassay and Potency Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Bioassay and Potency Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Bioassay and Potency Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Bioassay and Potency Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Bioassay and Potency Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Bioassay and Potency Testing Sales Value (2021-2032)
  16. 6.6.2 South America Bioassay and Potency Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Bioassay and Potency Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Bioassay and Potency Testing Sales Value Share by Country, 2025 VS 2032
7 Bioassay and Potency Testing Country-level Value Analysis
  1. 7.1 Global Bioassay and Potency Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bioassay and Potency Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Bioassay and Potency Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Bioassay and Potency Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Bioassay and Potency Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Bioassay and Potency Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Bioassay and Potency Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eurofins
  2. 8.1.1 Eurofins Company Information
  3. 8.1.2 Eurofins Business Overview
  4. 8.1.3 Eurofins Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eurofins Bioassay and Potency Testing Product Portfolio
  6. 8.1.5 Eurofins Recent Developments
  7. 8.2 Vimta Labs Ltd.
  8. 8.2.1 Vimta Labs Ltd. Company Information
  9. 8.2.2 Vimta Labs Ltd. Business Overview
  10. 8.2.3 Vimta Labs Ltd. Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Vimta Labs Ltd. Bioassay and Potency Testing Product Portfolio
  12. 8.2.5 Vimta Labs Ltd. Recent Developments
  13. 8.3 WaveCyte BioLabs
  14. 8.3.1 WaveCyte BioLabs Company Information
  15. 8.3.2 WaveCyte BioLabs Business Overview
  16. 8.3.3 WaveCyte BioLabs Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 WaveCyte BioLabs Bioassay and Potency Testing Product Portfolio
  18. 8.3.5 WaveCyte BioLabs Recent Developments
  19. 8.4 Reaction Biology
  20. 8.4.1 Reaction Biology Company Information
  21. 8.4.2 Reaction Biology Business Overview
  22. 8.4.3 Reaction Biology Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Reaction Biology Bioassay and Potency Testing Product Portfolio
  24. 8.4.5 Reaction Biology Recent Developments
  25. 8.5 Charles River Laboratories
  26. 8.5.1 Charles River Laboratories Company Information
  27. 8.5.2 Charles River Laboratories Business Overview
  28. 8.5.3 Charles River Laboratories Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Charles River Laboratories Bioassay and Potency Testing Product Portfolio
  30. 8.5.5 Charles River Laboratories Recent Developments
  31. 8.6 Intertek
  32. 8.6.1 Intertek Company Information
  33. 8.6.2 Intertek Business Overview
  34. 8.6.3 Intertek Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Intertek Bioassay and Potency Testing Product Portfolio
  36. 8.6.5 Intertek Recent Developments
  37. 8.7 Pacific BioLabs
  38. 8.7.1 Pacific BioLabs Company Information
  39. 8.7.2 Pacific BioLabs Business Overview
  40. 8.7.3 Pacific BioLabs Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pacific BioLabs Bioassay and Potency Testing Product Portfolio
  42. 8.7.5 Pacific BioLabs Recent Developments
  43. 8.8 FyoniBio
  44. 8.8.1 FyoniBio Company Information
  45. 8.8.2 FyoniBio Business Overview
  46. 8.8.3 FyoniBio Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 FyoniBio Bioassay and Potency Testing Product Portfolio
  48. 8.8.5 FyoniBio Recent Developments
  49. 8.9 Svar Life Science
  50. 8.9.1 Svar Life Science Company Information
  51. 8.9.2 Svar Life Science Business Overview
  52. 8.9.3 Svar Life Science Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Svar Life Science Bioassay and Potency Testing Product Portfolio
  54. 8.9.5 Svar Life Science Recent Developments
  55. 8.10 Solvias
  56. 8.10.1 Solvias Company Information
  57. 8.10.2 Solvias Business Overview
  58. 8.10.3 Solvias Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Solvias Bioassay and Potency Testing Product Portfolio
  60. 8.10.5 Solvias Recent Developments
  61. 8.11 Bioassay GmbH
  62. 8.11.1 Bioassay GmbH Company Information
  63. 8.11.2 Bioassay GmbH Business Overview
  64. 8.11.3 Bioassay GmbH Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bioassay GmbH Bioassay and Potency Testing Product Portfolio
  66. 8.11.5 Bioassay GmbH Recent Developments
  67. 8.12 Clean Cells
  68. 8.12.1 Clean Cells Company Information
  69. 8.12.2 Clean Cells Business Overview
  70. 8.12.3 Clean Cells Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Clean Cells Bioassay and Potency Testing Product Portfolio
  72. 8.12.5 Clean Cells Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst